Henoch–Schönlein Purpura, HSP: Diagnosis and Management (S2:E12)

Today we are discussing the diagnosis and treatment of Henoch–Schönlein purpura, HSP with Jens Goebel, MD, and Robert Fuhlbrigge, MD. Dr. Goebel is the Chief of Nephrology at Children’s Colorado and professor of pediatrics at the University of Colorado School of Medicine. Dr. Fuhlbrigge is Chief of Rheumatology at Children’s Colorado and Professor of Pediatrics also at the University of Colorado School of Medicine.

 Key Points From This Episode:

• Effects of systemic corticosteroids on HSP symptoms and potential complications.
• The incidence of HSP in the community and what ages are most likely to be affected.
• Classification criteria for the onset of HSP in patients.
• Understanding the events and drive of HSP at a molecular level.
• Tests that are helpful to understand risk of progression or to confirm diagnosis of HSP.
• How often HSP patients who are at risk for nephritis should be screened.
• Treatment decisions for patients with more severe HSP and complications.
• The percentage of recurrent flares of HSP symptoms in patients.
• Unusual presentation of HSP symptoms in pediatric patients.